TB-500^↗↗

"TB-500"[Title/Abstract] OR "LKKTETQ"[Title/Abstract]

• Regulator and trial-registry searches and non-indexed reports require separate reconciliation.
• Full-text appraisal, study-family linkage and citation follow-up remain open.
• The BPC-157/TB4 combination report PMID34324435 is a citation lead outside this name query; the exact TB4 formulation has not been established. This ledger does not assert worldwide absence of human reports.
• PMID 26472487 describes a urine assay; whether TB-500 itself was administered to people is unresolved without the full report. No eligible human-administration report has been established in this query.

Showing 25 of 32 record decisions, with included studies and unresolved records first. The versioned data inventory retains every record and study-family link.

1. PubMed 26472487 — unresolved: Urine extraction method mentions the fragment, but sample origin and any human TB-500 administration are not established in the abstract. Full-text reconciliation is needed.
2. PubMed 42635865 — exclude: Secondary review or clinical-practice discussion; not a primary report of this fragment administered to people.
3. PubMed 42578445 — exclude: Secondary review or clinical-practice discussion; not a primary report of this fragment administered to people.
4. PubMed 41966639 — exclude: Secondary review or clinical-practice discussion; not a primary report of this fragment administered to people.
5. PubMed 42542926 — exclude: Animal administration or animal wound-healing study; not administration to people.
6. PubMed 42021992 — exclude: Secondary review or clinical-practice discussion; not a primary report of this fragment administered to people.
7. PubMed 41490200 — exclude: Secondary review or clinical-practice discussion; not a primary report of this fragment administered to people.
8. PubMed 41476424 — exclude: Secondary review or clinical-practice discussion; not a primary report of this fragment administered to people.
9. PubMed 41359360 — exclude: The abstract reports human corneal cells and a wound model; indexed species include mice. No human administration is described.
10. PubMed 40681595 — exclude: Unrelated acronym or term match; the reported exposure is not the TB-500 peptide fragment.
11. PubMed 38382158 — exclude: Animal administration or animal wound-healing study; not administration to people.
12. PubMed 35730516 — exclude: Unrelated acronym or term match; the reported exposure is not the TB-500 peptide fragment.
13. PubMed 33318598 — exclude: Unrelated acronym or term match; the reported exposure is not the TB-500 peptide fragment.
14. PubMed 31791503 — exclude: Unrelated acronym or term match; the reported exposure is not the TB-500 peptide fragment.
15. PubMed 30063851 — exclude: Analytical, synthesis or cell/tissue experiment; no primary report of administration to people.
16. PubMed 28887173 — exclude: Analytical, synthesis or cell/tissue experiment; no primary report of administration to people.
17. PubMed 27569051 — exclude: Analytical, synthesis or cell/tissue experiment; no primary report of administration to people.
18. PubMed 26578461 — exclude: Analytical method includes TB-500, but the described human elimination samples concern GHRP-6, GHRP-2 or LHRH, not TB-500.
19. PubMed 25469748 — exclude: Analytical, synthesis or cell/tissue experiment; no primary report of administration to people.
20. PubMed 25382550 — exclude: Secondary review or clinical-practice discussion; not a primary report of this fragment administered to people.
21. PubMed 24906629 — exclude: Secondary review or clinical-practice discussion; not a primary report of this fragment administered to people.
22. PubMed 23318763 — exclude: Animal administration or animal wound-healing study; not administration to people.
23. PubMed 23084823 — exclude: Animal administration or animal wound-healing study; not administration to people.
24. PubMed 22962027 — exclude: Analytical, synthesis or cell/tissue experiment; no primary report of administration to people.
25. PubMed 20179146 — exclude: Secondary review or clinical-practice discussion; not a primary report of this fragment administered to people.

products.active_ingredients.name:"TB-500"

• Zero results describe this query response only, not absence of FDA approval or worldwide nonapproval.
• This endpoint does not inventory every label, advisory proceeding, safety communication or regulatory document. Application inclusion does not establish current marketing or approval of every use.

Showing 0 of 0 record decisions, with included studies and unresolved records first. The versioned data inventory retains every record and study-family link.

Case-insensitive word-boundary identity terms: ["TB-500", "N-terminal acetylated 17-23 fragment of thymosin beta-4"]

• Document appraisal and national European sources remain open.
• Zero matches apply only to these feed fields and terms; orphan designation is not approval.

Showing 0 of 0 record decisions, with included studies and unresolved records first. The versioned data inventory retains every record and study-family link.

Case-insensitive word-boundary identity terms: ["TB-500", "N-terminal acetylated 17-23 fragment of thymosin beta-4"]

• Document appraisal and national European sources remain open.
• Zero matches apply only to these feed fields and terms; orphan designation is not approval.

Showing 0 of 0 record decisions, with included studies and unresolved records first. The versioned data inventory retains every record and study-family link.

Case-insensitive word-boundary identity terms: ["TB-500", "N-terminal acetylated 17-23 fragment of thymosin beta-4"]

• Document appraisal and national European sources remain open.
• Zero matches apply only to these feed fields and terms; orphan designation is not approval.

Showing 0 of 0 record decisions, with included studies and unresolved records first. The versioned data inventory retains every record and study-family link.

"TB-500" OR "N-terminal acetylated 17-23 fragment of thymosin beta-4"

• Registration is not evidence that a study succeeded, that results were published, or that a use is approved.
• Other registries, unregistered studies and additional aliases remain outside this query.

Showing 1 of 1 record decisions, with included studies and unresolved records first. The versioned data inventory retains every record and study-family link.

1. ClinicalTrials.gov NCT07487363 — not screened: Registry name-query match awaiting intervention identity, study-family linkage and results appraisal.